Publication | Open Access
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
93
Citations
33
References
2015
Year
Pilot Clinical TrialSystemic SclerodermaMedicineSystemic TreatmentClinical TrialsPharmacotherapyNeurologyNeuroimmunology
| Year | Citations | |
|---|---|---|
Page 1
Page 1